NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
Description
NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide.
Offer reference number: CM/PHG/24/5716
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Periods of call-offs under the framework agreement:
CM/PHG/24/5716/01– NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide.
CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028
NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028
LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
The rest of this notice
The tender documents, the buyer's named contact, the award history and our AI analysis for this notice are part of Pro. Start a free trial to open the full record.
- Download the tender documents
- Contact the buyer directly
- See who won, and for how much
- Read the AI analysis of scope and risk
- Get alerts for tenders like this one
14 days free. No card required.
Guides for bidders
New to public sector tendering? These short guides explain how the process works.